AP2984A - An arteether injection for treatment of malaria - Google Patents
An arteether injection for treatment of malariaInfo
- Publication number
- AP2984A AP2984A AP2011005552A AP2011005552A AP2984A AP 2984 A AP2984 A AP 2984A AP 2011005552 A AP2011005552 A AP 2011005552A AP 2011005552 A AP2011005552 A AP 2011005552A AP 2984 A AP2984 A AP 2984A
- Authority
- AP
- ARIPO
- Prior art keywords
- arteether
- malaria
- injection
- treatment
- arteether injection
- Prior art date
Links
- NLYNIRQVMRLPIQ-XQLAAWPRSA-N artemotil Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OCC)O[C@H]4[C@]32OO[C@@]1(C)O4 NLYNIRQVMRLPIQ-XQLAAWPRSA-N 0.000 title 1
- 229960002970 artemotil Drugs 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN97MU2009 | 2009-01-14 | ||
| PCT/IN2009/000757 WO2010082219A2 (en) | 2009-01-14 | 2009-12-30 | An arteether injection for treatment of malaria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2011005552A0 AP2011005552A0 (en) | 2011-02-28 |
| AP2984A true AP2984A (en) | 2014-09-30 |
Family
ID=42340178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2011005552A AP2984A (en) | 2009-01-14 | 2009-12-30 | An arteether injection for treatment of malaria |
Country Status (2)
| Country | Link |
|---|---|
| AP (1) | AP2984A (en) |
| WO (1) | WO2010082219A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020089942A2 (en) | 2018-11-02 | 2020-05-07 | Amaterasu Lifesciences Llp | A liquid injectable composition |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000044333A2 (en) * | 1999-01-28 | 2000-08-03 | Dinesh Shantilal Patel | Novel injectable antimalarial compositions of artemisinin |
| WO2004071509A1 (en) * | 2003-02-12 | 2004-08-26 | Nippon Chemiphar Co., Ltd. | Oligodendrocyte differentiation promoters |
| CN1650854A (en) * | 2004-12-08 | 2005-08-10 | 广州中生生物技术有限公司 | Preparation technology of micro emulsion containing artemisic methyl ether (or artemisic ethyl ether or artemisic succinate) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393672A (en) * | 2003-02-12 | 2013-11-20 | 乔治敦大学 | Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
-
2009
- 2009-12-30 WO PCT/IN2009/000757 patent/WO2010082219A2/en not_active Ceased
- 2009-12-30 AP AP2011005552A patent/AP2984A/en active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000044333A2 (en) * | 1999-01-28 | 2000-08-03 | Dinesh Shantilal Patel | Novel injectable antimalarial compositions of artemisinin |
| WO2004071509A1 (en) * | 2003-02-12 | 2004-08-26 | Nippon Chemiphar Co., Ltd. | Oligodendrocyte differentiation promoters |
| CN1650854A (en) * | 2004-12-08 | 2005-08-10 | 广州中生生物技术有限公司 | Preparation technology of micro emulsion containing artemisic methyl ether (or artemisic ethyl ether or artemisic succinate) |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010082219A4 (en) | 2010-12-23 |
| WO2010082219A2 (en) | 2010-07-22 |
| AP2011005552A0 (en) | 2011-02-28 |
| WO2010082219A3 (en) | 2010-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2512236T3 (en) | Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) | |
| IL215516A0 (en) | Emulsions of perfluorocarbons | |
| GB0918145D0 (en) | Injector apparatus | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| GB201207472D0 (en) | Novel parasite therapy | |
| SMT202100713T1 (en) | Infusion of drugs | |
| IL215865B (en) | Formulation of meloxicam | |
| IL206491A0 (en) | Treatment of produce | |
| ZA201109514B (en) | Method of drug delivery | |
| ZA201003844B (en) | Delivery of functional compounds | |
| IL215377A0 (en) | Method of genotyping | |
| IL216119A0 (en) | Method of decreasing ubiquitylated protein levels | |
| IL213955A0 (en) | Method for improved bioactivation of medications | |
| ZA201300083B (en) | New drug combinations for the treatment of malaria | |
| EG26793A (en) | Medical injector | |
| GB0908101D0 (en) | Treatment of stress | |
| PL2493305T3 (en) | 2-aminoindole compounds and methods for the treatment of malaria | |
| AP2984A (en) | An arteether injection for treatment of malaria | |
| EP2424539A4 (en) | Method of treatment of depression | |
| EP2404891A4 (en) | Preparation method of acylbenzenes | |
| TWM370404U (en) | Structure of compound massage set | |
| GB0900114D0 (en) | An improved method of coving | |
| GB0904164D0 (en) | Method of treatment | |
| GB0909807D0 (en) | Method of treatment | |
| GB0921823D0 (en) | Method of treatment |